118 related articles for article (PubMed ID: 17219330)
41. [Synchronous cancers of the esophagus and of the ORL area: results of combined treatments with esophagectomy (28 cases)].
Elias D; Mamelle G; el Malt O; Luboinski B; Schwaab G; Spielmann M; Girinsky T; Nitenberg G; Kac J; Lasser P
Bull Cancer; 1991; 78(2):173-8. PubMed ID: 2036488
[TBL] [Abstract][Full Text] [Related]
42. [Clinical and epidemiological data of patients with malignomas of the head and neck].
Lang S; Wollenberg B; Dellian M; Steuer-Vogt MK; Schwenzer K; Sautier W; Chucholowski M; Eckel R; Faas I; Wilmes E; Ehrenfeld M; Arnold W; Kastenbauer E; Hölzel D
Laryngorhinootologie; 2002 Jul; 81(7):499-508. PubMed ID: 12173061
[TBL] [Abstract][Full Text] [Related]
43. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Nishimura G; Nagao J
Auris Nasus Larynx; 2009 Apr; 36(2):199-204. PubMed ID: 18632233
[TBL] [Abstract][Full Text] [Related]
44. [Lymph node metastasis in head-neck tumors].
Remmert S; Rottmann M; Reichenbach M; Sommer K; Friedrich HJ
Laryngorhinootologie; 2001 Jan; 80(1):27-35. PubMed ID: 11272244
[TBL] [Abstract][Full Text] [Related]
45. Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period.
Eckardt A; Barth EL; Kokemueller H; Wegener G
Oral Oncol; 2004 Apr; 40(4):427-32. PubMed ID: 14969822
[TBL] [Abstract][Full Text] [Related]
46. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
[TBL] [Abstract][Full Text] [Related]
47. [The status of sequential chemo-/radiotherapy in inoperable head and neck cancers. Personal results and review of the literature].
Volling P
HNO; 1991 Jul; 39(7):254-9. PubMed ID: 1938489
[TBL] [Abstract][Full Text] [Related]
48. [Palliative intraoperative irradiation of recurrent neck lymph node metastases in the head and neck area].
Spaeth J; Andreopoulos D; Unger T
Laryngorhinootologie; 1997 Jan; 76(1):36-41. PubMed ID: 9156507
[TBL] [Abstract][Full Text] [Related]
49. [Current opinion in treatment of soft tissue sarcoma].
Dietz A; Frerich B
Laryngorhinootologie; 2009 May; 88(5):293-302. PubMed ID: 19391071
[TBL] [Abstract][Full Text] [Related]
50. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
51. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
52. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
53. [Coagulation factors as potential tumour markers in patients with head and neck carcinomas?].
Greve J; Schuler PJ; Bas M; Adamzik M; Brandau S; Arweiler-Harbeck D; Lang S; Hoffmann TK
Laryngorhinootologie; 2010 Oct; 89(10):612-5. PubMed ID: 20628968
[TBL] [Abstract][Full Text] [Related]
54. [Best supportive care in head and neck cancer].
Salzwimmer M
Wien Med Wochenschr; 2008; 158(9-10):278-82. PubMed ID: 18560955
[TBL] [Abstract][Full Text] [Related]
55. Circulating and disseminated tumour cells in head and neck cancer.
Harris AT; Derbyshire S; Wilson J; Loh C; Kinshuck AJ; Attlmayr B; Jones TM
J Laryngol Otol; 2015 Sep; 129(9):826-30. PubMed ID: 26174011
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis and therapeutic pathways in head and neck cancers].
Dubois M; Ballivet de Régloix S; Raynal M; Lepage P; Kossowski M; Pons Y
Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):81-8. PubMed ID: 24683817
[TBL] [Abstract][Full Text] [Related]
57. [Head and neck cancers in geriatric patients].
Güney E; Cağli S; Yüce I
Kulak Burun Bogaz Ihtis Derg; 2009; 19(1):45-54. PubMed ID: 19793048
[TBL] [Abstract][Full Text] [Related]
58. Toward comprehensive multidisciplinary care for head and neck cancer patients: quality of life versus survival.
Morton RP
Otolaryngol Head Neck Surg; 2012 Sep; 147(3):404-6. PubMed ID: 22687328
[TBL] [Abstract][Full Text] [Related]
59. New developments for optimal management of head and neck cancer.
de Bree R; Leemans CR
Onkologie; 2004 Aug; 27(4):339-42. PubMed ID: 15376363
[No Abstract] [Full Text] [Related]
60. [Current therapy options in recurrent head and neck cancer].
Boehm A; Wichmann G; Mozet C; Dietz A
HNO; 2010 Aug; 58(8):762-9. PubMed ID: 20628714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
